Can a stronger jolt to the brain beat treatment-resistant depression?
NCT ID NCT02942368
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small pilot study tested a noninvasive brain stimulation technique called tDCS in 5 adults with major depression that hadn't improved after at least 3 antidepressant trials. Participants received up to 20 sessions of higher-than-usual electrical current over 4 to 6 weeks. The study was terminated early, so the results are very limited and not conclusive.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial direct current stimulation (tDCS) device
- What this could lead to
- If it works, this could point toward a non-drug option for people with depression that hasn't responded to multiple medications.
- What could go wrong
- This was a very small pilot study with only 5 participants and it was terminated early. Higher doses may cause side effects, and the approach is still highly experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
5 people
The number who actually took part.
- Started
-
Apr 2017
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults age 18 to 65 2. History of major depressive disorder with current depressive symptoms, as defined by DSM-IV criteria 3. Baseline score of Hamilton Depression Rating Scale 17-item (HDRS-17) score of 17 or higher 4. Failure of at least 3 prior lifetime antidepressant trials 5. Good command of the English language Exclusion Criteria: 1. Lifetime history of the following, defined by DSM-IV criteria per study physician: 1. Moderate or severe substance use disorder in the past 6 months with the exception of nicotine use disorder 2. Dementia or major neurocognitive disorder 3. Schizophrenia spectrum disorders 4. Autism spectrum disorder 5. Depression which has failed to respond to ECT, with treatment failure as determined by evaluating physician 6. Failure of greater than 6 antidepressant trials in the current depressive episode 2. Current evidence of the following, defined by present symptomology as per study physician: 1. Active psychotic symptoms 2. Bipolar disorder with a current manic, hypomanic, or mixed episode as defined by DSM-IV criteria 3. Depression secondary to a general medical illness 4. Dysphoria better explained by a personality disorder 5. Dysphoria associated with a primary anxiety disorder or PTSD 6. Active suicidal intention (inability to contract for safety) 7. Any change in psychotropic medication within 30 days of the initiation of tDCS 8. History of neurological disorders (e.g., epilepsy) and/or off any treatment medication for a neurological disorder for minimum 3 years (36 months) 9. Any open wounds (e.g., blisters, burns including sun burns, cuts or irritation) under or near the scalp regions where electrodes are placed 10. Metal implants (e.g., Deep Brain Stimulator, Vagus Nerve Stimulator) 11. Any skin disorders (e.g., eczema, severe rashes, sensitive skin, any communicable skin disorder or treatment for a communicable skin disorder in the past 12 months) or other skin defects which compromise the integrity of the skin at or near stimulation locations (where electrodes are placed) 12. Any history of head injury resulting in unconsciousness for more than 5 minutes (e.g., head trauma, brain surgery) 13. Metallic face or scalp tattoos 14. Any chronic headaches or migraines (occurring for consecutive days and are longer than an hour) 15. If a participant has a change in the rate or severity of head pressure, headache, or migraine in the past two weeks, they will also be excluded as per study clinician as we are not aiming to assess the treatment of headache with tDCS 16. Any personal history of seizures. 3. Currently pregnant or lactating, as determined in part from urine pregnancy test at Screening/Baseline appointment and medical history. 4. Any other factor that in the investigators' judgment may affect patient safety or compliance (e.g. distance greater than 100 miles from clinic)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive disorder, treatment-resistant are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University in Saint Louis
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Brain-Signaling drug crack depression that resists standard treatment?
- Can a psychedelic drug lift depression that won't budge?
- Brain implants and nerve stimulation put to the test for untreatable depression
- One-Day brain zaps: a new hope for stubborn depression?
- Nasal spray could offer new hope for Treatment-Resistant depression
- Experimental depression drug aims to help when standard meds fail